#PolicyMaking
LightNews LightNews
socpaperbot.bsky.social
Quantifying the Rise in Anti-Vaccine Policymaking Across State Legislatures Through the State Vaccine Policy Project (SVPP). Since the onset of the COVID-19 pandemic, lawmakers across the US have introduced legislation aimed at weakening existing vaccine-related policies (e.g., v
#sociology link
November 11, 2025 at 8:33 PM
g-pec.bsky.social
😂 … Oversight, we don’t need no stinkin’ oversight … says the Petroleum Industry
Except: “a commissioner on the U.S. Arctic Research Commission, or USARC, is the latest sign of turmoil within the Arctic research and policymaking community since U.S. President Donald Trump took office in January.”
November 11, 2025 at 7:46 PM
ylepidemiologist.bsky.social
7/ Their goal is to restore expert-led vaccine policymaking and their review is a major step toward protecting evidence-based decisions in child health.

👉 www.cidrap.umn.edu/hepatitis/ne...
Next up for Vaccine Integrity Project: reviewing data on birth dose of hepatitis B vaccine
www.cidrap.umn.edu
November 11, 2025 at 7:25 PM
fsi.stanford.edu
Empathy is a simple but profound mechanism for building social cohesion, says @claireadida.bsky.social of @stanfordcddrl.bsky.social.

Using quantitative and field methods, Adida studies what creates or dissolves cohesion, and how that can be used to inform better policymaking.
Meet Our Researchers: Dr. Claire Adida
Exploring how empathy and perspective-taking shape migration, inclusion, and public attitudes toward diversity with FSI Senior Fellow Claire Adida
ow.ly
November 11, 2025 at 7:20 PM
unu-wider.bsky.social
During his visit to South Africa’s National Treasury Secure Data Facility, @ununiversity.bsky.social Rector Tshilidzi Marwala met colleagues from #SATIED to see how the programme transforms administrative data into research insights that inform economic policymaking.

More: go.unu.edu/plOLR
November 11, 2025 at 5:57 PM
stephenkb.bsky.social
USA PISA scores *are* a crock of shit IMO, because there is no national curriculum so you really are getting absolutely no useful signal out of them. Would be much more useful for policymaking across the world if they were entered as states, not as one country.
November 11, 2025 at 4:56 PM
melanienewport.bsky.social
a contribution of my book that I’m proud of: I unravel the myth of good intentions that animates carceral politics and a lot of contemporary liberalism. racist intent matters. harmful outcomes in policymaking matter. www.pennpress.org/978151282349...
This Is My Jail – Penn Press
While state and federal prisons like Attica and Alcatraz occupy a central place in the national consciousness, most incarceration in the United States occurs...
www.pennpress.org
November 11, 2025 at 2:27 PM
quantumproject.bsky.social
We are very glad to be at the European Public Health Conference in Helsinki 🇫🇮 with a pre-conference session dedicated to QUANTUM, and how it aims to ensure Health Data Quality for better public health research and policymaking. #EPH2025
November 11, 2025 at 2:08 PM
heywoodquarterly.bsky.social
Why does economic dynamism matter?
Stephen Aldridge, Director of Analysis and Data at the MHCLG, highlights three charts with a striking message for the UK.
heywoodquarterly.com/why-economic...
#Policymaking #LongTerm #Economy #Growth
November 11, 2025 at 12:53 PM
Firstly, remove lobbyists for the food producers from all policymaking bodies.
November 11, 2025 at 12:45 PM
deejayquai.bsky.social
Rising unemployment. Rising youth unemployment. High levels of economic inactivity. A Get Britain Working policy that is failing to...work, exacerbated by myopic devolved policymaking, more focused on process than outcome.
November 11, 2025 at 10:32 AM
tcrgbath.bsky.social
📢 Announcing the UK Tobacco Industry Interference Index 2025, part of the Global Tobacco Industry Interference Index.

The UK is ranked 17 out of 100 countries, based on evidence captured between April 2023 and March 2025.

www.bath.ac.uk/case-studies/the-uk-tobacco-industry-interference-index-2025/
“The 2025 UKTI shows an improvement in how the UK government is responding to these interference attempts, when compared to the 2023 report, while showing that the industry continues to be a key threat to independent policymaking.”
November 11, 2025 at 10:03 AM
schoolforgovt.bsky.social
EVENT | Dame Tamara Finkelstein DCB: in conversation

Join us for a special event with Tamara Finkelstein, one of the UK’s most experienced former civil servants, as she reflects on intelligent and innovative policymaking in an age of uncertainty

➡️ www.kcl.ac.uk/events/dame-t...
November 11, 2025 at 9:00 AM
2rzikkbou3ntafnir2qmmse0gwz.activitypub.awakari.com.ap.brid.gy
NITDA emerges as Nigeria’s digital super-regulator under new bill The National Digital Economy and E-Governance Bill hands sweeping powers to the National Information Technology Development Agenc...

#Policy #Digital #Economy #Nigeria #NITDA #Policymaking […]

[Original post on techcabal.com]
Original post on techcabal.com
techcabal.com
November 11, 2025 at 7:56 AM
thirugeneva.bsky.social
A Turning Point That Left Millions Behind
By Barton Gellman
Washington Post Staff Writer
Thursday, December 28, 2000
www.washingtonpost.com/wp-dyn/conte...
Plus ça change @who.int @bartongellman.bsky.social
"GENEVA -- Raymond V. Gilmartin's private jet touched down at Geneva-Cointrin airport near midnight on March 26. Early next morning, on four hours' sleep, he sped to the hilltop headquarters of the World Health Organization. His name appeared on no calendar, but he was expected. He carried the brief of a $ 350 billion industry on the run. Two years of public censure, with charges of profiteering on history's worst pandemic, had brought the manufacturers of AIDS medicines close to pariah status in U.N. forums. Declarations known as "soft law" threatened the value of their patents. Their reputations as health-givers had suffered as 35 million people with HIV--25 million in Africa--faced death without the drugs that could prolong their lives. Merck, the New Jersey drug giant for which Gilmartin was chairman and chief executive, had begun to compare the stakes with those faced by infant formula makers accused of promoting breast milk substitutes in countries where they did more harm than good. "No matter what Nestle could do or say, they never really managed to get over that slogan that they killed babies," one manager said. Gilmartin had come to WHO Conference Room 7079 to reveal an industry secret. Facing Director General Gro Harlem Brundtland and a panoramic Alpine view, he said that five major pharmaceutical companies had committed in principle to substantial discounts on their AIDS medicines in poor countries. The conditions of their offer, broadly drafted, included burden-sharing by governments and reinforced protection of the industry's patents. Now Gilmartin wanted to know: Would Brundtland care to sponsor the initiative and take a leading role in its announcement? "In the late 1990s, an unexpected synergy between AIDS activists and critics of globalization started eating away at the political framework that supported the boom. AIDS organizers tormented Vice President Gore's presidential campaign and chained themselves to desks in Trade Representative Charlene Barshefsky's office, pressing the Clinton administration to stop backing the industry against generic competitors. The slogans of the activists--"Pfizer's Greed Kills," "Death Under Patent," "Medical Apartheid"--sliced into the industry's long-standing efforts "to portray itself as being driven by improving the human condition," said Michael Artinger of Decision Resources, a pharmaceutical research firm. On Dec. 1, 1999, President Clinton announced a new trade and patent policy "flexible enough" that "people in the poorest countries won't have to go without medicine they so desperately need." Pharmaceutical executives anticipated further setbacks at a May 15 gathering of health ministers in Geneva, and at July's international AIDS conference in Durban, South Africa. As U.N. Deputy Secretary General Louise Frechette said in an interview, AIDS had "gone up quite a bit in the cosmic scale of priorities." "Four days later, Bruntland, the WHO director general, gave her second annual speech to the policymaking executive board. Much of it centered on AIDS. "Squarely put, the drugs are in the north and the disease is in the south," Brundtland said. "I wish to invite the pharmaceutical industry to join us in taking a fresh and constructive look at how we can considerably increase access to relevant drugs." A teleconference on Feb. 8 brought high-ranking officers of the six companies into the talks for the first time. Among them were Weg of Bristol-Myers; Glaxo Executive Director James Cochrane; Per Wold-Olsen, Merck president for Europe, Middle East and Africa; Pfizer Senior Vice President Ian C. Read; Boehringer corporate marketing director Riku Rautsola; and Roche's global pharmaceutical chief, William M. Burns. ad_icon To a man, they were frustrated. "We've got to get off the subject of prices!" Burns exploded, speaking from his headquarters in Basel, Switzerland. "Prices are not the issue." At the first mention of prices, lawyers chimed in from speakerphones. They cautioned the executives to steer clear of price-setting, for fear of antitrust violations. But that was not where this conversation was going. Some of the participants, including Cochrane, wanted to take on the industry's critics--above all Bernard Pecoul of the French medical aid group Doctors Without Borders, and James Love of the Consumer Project on Technology in Washington. According to participants, Jeffrey L. Sturchio of Merck and Glaxo's Ben Plumley, public affairs specialists, said that would be a losing battle. The only way to turn perceptions around, Sturchio said, was "to make something affirmative happen," including substantial price cuts. That view was not unanimous. Pfizer's Read registered strong dissent, and Pfizer withdrew."
November 11, 2025 at 1:30 AM
europesays.bsky.social
Navigating the complexity of European policymaking on China

https://www.europesays.com/2560483/

Report November 10, 2025 • 10:00 am ET Print this page Navigating the complexity of European policymaking on…
Navigating the complexity of European policymaking on China - EUROPE SAYS
Report
www.europesays.com
November 10, 2025 at 10:45 PM
nyucic.bsky.social
🙌 We commend the #JusticeActionCoalition and World Justice Project for their exceptional commitment to data and evidence to improve justice globally through the 2025 Rule of Law Index. Data and evidence are the foundation for people-centered policymaking.
November 10, 2025 at 9:10 PM
bigearthdata.bsky.social
Navigating the complexity of European policymaking on China
->Atlantic Council | More from Lil Dr Glen EcoChat at BigEarthData.ai
Navigating the complexity of European policymaking on China
This is the second chapter of the report “Is Europe waking up to the China challenge? How geopolitics are reshaping EU and transatlantic strategy.” Read the full report here. In a well-known anecdote often attributed to Henry Kissinger, the national...
www.atlanticcouncil.org
November 10, 2025 at 8:57 PM
bettycjung.bsky.social
The American Academy of Pediatrics (AAP) filed an updated lawsuit last week against HHS Secretary RFK Jr., to disband a panel (ACIP) appointed by RFK Jr. & overturn recent decisions made by that panel. Then, proceed under court supervision. Legal move is to restore expert-led vaccine policymaking.
November 10, 2025 at 6:49 PM
brumidigroup.bsky.social
In our latest video, Brumidi Group Managing Partner Charles Cooper gives insight into how organizations can take advantage of policymaking going into the new year.
November 10, 2025 at 5:45 PM
sbcasociety.bsky.social
An author of over 300 articles, book chapters, reports, and essays, Coglianese’s research focuses on administrative law and regulatory processes, exploring the role of public participation, technology, and business-government relations in policymaking.
November 10, 2025 at 5:05 PM
eduardoelreportero.bsky.social
Who gets hurt when Trump's crazy policymaking bumps the dollar from its perch as global reserve currency? My latest for The Guardian www.theguardian.com/business/202...
Trump’s dollar delusion: how trade war risks ending the US’s ‘exorbitant privilege’
Trump’s team flirts with weakening the dollar, threatening US influence, low borrowing costs and global stability
www.theguardian.com
November 10, 2025 at 4:50 PM
scumbagnobody.bsky.social
what counts for left in this country is barely centrism.

We cannot even solve the baseline problems a country should solve. Food, Homelessness, and water.

We also have extremely bad infrastructure......everywhere.

both of those are just failures of policymaking
November 10, 2025 at 4:49 PM
esci.eu
🌍 A new global study in finds that most people still trust scientists & want them more involved in society & policymaking. Far from a crisis of trust, this is a reminder that effective science communication should build on that trust.🧪
www.nature.com/articles/s41...
Trust in scientists and their role in society across 68 countries - Nature Human Behaviour
What is the state of trust in scientists around the world? To answer this question, the authors surveyed 71,922 respondents in 68 countries and found that trust in scientists is moderately high.
www.nature.com
November 10, 2025 at 4:14 PM
uk-news.bsky.social
Navigating the complexity of European policymaking on China

https://www.europesays.com/uk/561673/

Report November 10, 2025 • 10:00 am ET Print this page Navigating the complexity of European policymaking on…#uk #news #uknews
Navigating the complexity of European policymaking on China - United Kingdom
Report
www.europesays.com
November 10, 2025 at 4:00 PM